Unispas 10 mg/250 mg Tablet
By Unispas
Rx
10 Tablet in a Strip

Composition
Dicyclomine(10mg) + Mefenamic Acid(250mg)

Manufacturer - Rhombus Pharma Pvt Ltd
B-18, Galaxy Signature, Opp. Shukan Bungalows, Science City Road, Sola -380-060.

Expires on or after
October, 2025

liver
When using Unispas 10 mg/250 mg Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of the tablet in such cases. It is advised to consult with your doctor regarding the use of Unispas 10 mg/250 mg Tablet if you have liver issues.

kidney
Unispas 10 mg/250 mg Tablet needs caution in kidney disease patients. Dosage adjustment may be necessary. Avoid in severe kidney disease. Consulting your doctor is advised.

alcohol
When taking Unispas 10 mg/250 mg Tablet, be cautious if consuming alcohol. It's recommended to consult with your doctor regarding alcohol intake.

driving
Caution while driving is important when taking Unispas 10 mg/250 mg Tablet. If you have symptoms that make it hard to focus or react, avoid driving. It is uncertain if Unispas 10 mg/250 mg Tablet impacts driving ability.

pregnancy
It is better to consult your doctor before using Unispas 10 mg/250 mg Tablet during pregnancy as information regarding its safety during this time is not available.

breastfeeding
It is better to consult your doctor before using Unispas 10 mg/250 mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹25
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024